Elicio Therapeutics, Inc. (ELTX) › Cost of RevenueElicio Therapeutics, Inc. (ELTX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2020: $1.19M2021: $433.0K2022: $0$02020Cost of Revenue (USD)2022Fiscal YearCost of RevenueChange YoY2022$0-100.0%2021$433.0K-63.6%2020$1.19M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share